| Literature DB >> 29147585 |
Chien-Heng Chu1, Arthur F Kramer2,3, Tai-Fen Song1, Chih-Han Wu1, Tsung-Min Hung4, Yu-Kai Chang1.
Abstract
The purpose of this study was to examine the effect of a single bout of exercise on neurocognitive function in preadolescent children and young adults by determining the modulatory role of age and the neuroelectrical mechanism(s) underlying the association between acute exercise and executive function. Twenty preadolescents and 20 young adults completed the Stroop test, and neuroelectrical activity was recorded during two treatment sessions performed in a counterbalanced order. Exercise treatments involved moderate intensity aerobic exercise for 20 min as the main exercise and two 5 min periods of warm-up and cool-down. The control treatment participants read for a similar duration of time. Acute exercise improved participant reaction times on the Stroop test, regardless of Stroop congruency, and greater beneficial effects were observed in young adults compared to those in preadolescents. The P3 amplitudes increased after acute exercise in preadolescents and young adults, but acute exercise induced lower conflict sustained potential (conflict SP) amplitudes in preadolescent children. Based on these findings, age influences the beneficial effect of acute exercise on cognitive performance in general. Furthermore, the event-related brain potential differences attributed to acute exercise provide a potential clue to the mechanisms that differentiate the effects of acute exercise on individuals from preadolescence to young adulthood.Entities:
Mesh:
Year: 2017 PMID: 29147585 PMCID: PMC5632908 DOI: 10.1155/2017/2631909
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Participant demographic characteristics (mean ± 1 SD; range).
| Variable | Group | |
|---|---|---|
| Preadolescent children | Young adults | |
| Sample size | 20 | 20 |
| Gender (female: male) | 0 : 20 | 2 : 18 |
| Age (yrs) | 10.50 ±. 53; 10-11 | 20.42 ± 1.16; 19–23 |
| Education (yrs) | 4.40 ± .52; 4-5 | 14.33 ± 1.37; 13–18 |
| Height (cm) | 146.30 ± 8.79; 138.00–167.00 | 169.75 ± 5.82; 156.00–178.00 |
| Weight (kg) | 40.00 ± 6.13; 30.00–50.00 | 66.25 ± 10.80; 48.00–80.00 |
| BMI (kg·m−2) | 18.65 ± 2.14; 15.11–22.32 | 22.92 ± 3.13; 19.15–27.68 |
| Digit span forward | 14.30 ± 1.49; 11–16 | 14.50 ± 1.31; 12–16 |
| Digit span backward | 8.70 ± 2.40; 5–12 | 10.58 ± 2.97; 5–14 |
| VO2peak (mL·kg−1·min−1) | 50.60 ± 8.24; 46.43–68.07 | 49.18 ± 7.57; 44.16–65.43 |
| Resting heart rate | 70.20 ± 6.78; 59.00–86.00 | 65.50 ± 5.27; 56.00–73.00 |
Summary of statistical analyses of behavioral and ERP measures.
| Measure and effect | df |
|
|
|
|---|---|---|---|---|
|
| ||||
| Treatment | 1, 38 | 23.83 | <.0001 | .39 |
| Treatment × group | 1, 38 | 5.80 | =.021 | .13 |
| Congruency | 1, 38 | 60.65 | <.0001 | .62 |
| Congruency × group | 1, 38 | 4.62 | =.038 | .11 |
|
| ||||
| Treatment × group | 1, 38 | 7.03 | =.012 | .16 |
| Congruency | 1, 38 | 56.31 | <.0001 | .60 |
| Group | 1, 38 | 5.24 | =.028 | .12 |
|
| ||||
| Treatment | 1, 36 | 4.65 | =.038 | .11 |
| Congruency | 1, 36 | 24.66 | <.0001 | .41 |
| Congruency × group | 1, 36 | 9.02 | =.005 | .20 |
| Site | 2, 72 | 71.08 | <.0001 | .66 |
| Site × group | 2, 72 | 14.51 | <.0001 | .29 |
|
| ||||
| Treatment × group | 1, 36 | 7.00 | =.012 | .16 |
| Congruency | 1, 36 | 13.23 | =.001 | .27 |
| Site × group | 1, 36 | 4.61 | =.039 | .11 |
Note. Only significant effects were presented.
Figure 1(a) Interaction effect of treatment and group. (b) Interaction effects of condition and group. ∗Significant difference (p < 0.05).
Figure 2(a) Main effect of treatment and the interaction effect of congruency and group. (b) Stimulus-locked grand-average waveform at Fz, Cz, and Pz, collapsed across congruency in treatments and groups. (c) Topographic scalp distribution of the P3 amplitude collapsed across congruency in treatments and groups. ∗Significant difference within a group (p < 0.05).
Figure 3(a) Interaction effect of treatment and group and site and group. ∗Significant difference (p < 0.05). (b) Stimulus-locked grand-average waveform at the right and left central-parietal hemisphere collapsed across congruency in treatments and groups. (c) Topographic scalp distribution of the conflict SP amplitude collapsed across congruency in treatments and groups. ∗Significant difference within a group (p < 0.05); #Significant difference between groups (p < 0.05).